Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: A clinical trial

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Ouellette, Catherine ^a   Rudkowska, Iwona ^b   Lemieux, Simone ^a   Lamarche, Benoit ^a   Couture, Patrick ^a,b   Vohl, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b University Laval   (Canada)

Author keywords

LDL cholesterol; LDL particle size; MGLL; Nutrigenomics; Omega 3 polyunsaturated fatty acids

Indexed keywords

ACYLGLYCEROL LIPASE; CARBOHYDRATE; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PROTEIN; SATURATED FATTY ACID; LOW DENSITY LIPOPROTEIN;

ADULT; ALLELE; ARTICLE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PARTICLE SIZE; PROTEIN INTAKE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CLINICAL TRIAL; GENE LINKAGE DISEQUILIBRIUM; GENETICS;

ADULT; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, LDL; MALE; MONOACYLGLYCEROL LIPASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84901988937     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-86     Document Type: Article

References (54)

1. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Dyerberg J, Banga H, Stoffersena E, Moncadab S, Vaneb J, Lancet 1978 2 117 119 78322 (Pubitemid 8373454)
2. Dietary omega-3 fatty acid intake and cardiovascular risk. Psota TL, Gebauer SK, Kris-Etherton P, Am J Cardiol 2006 98 3I 18I 16919512
3. The role of marine n-3 fatty acids in improving cardiovascular health: a review. Nicholson T, Khademi H, Moghadasian MH, Food Funct 2013 4 357 365 10.1039/c2fo30235g 23325431
4. Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy. von Schacky C, Ann Intern Med 1987 107 890 899 10.7326/0003-4819-107-6-890 2825573 (Pubitemid 18014243)
5. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Davidson MH, AmJ Cardiol 2006 98 27i 33i
6. Why do omega-3 fatty acids lower serum triglycerides? Harris WS, Bulchandani D, Curr Opin Lipidol 2006 17 387 393 10.1097/01.mol.0000236363. 63840.16 16832161 (Pubitemid 44079475)
7. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Hokanson JE, Austin MA, J CardiovascRisk 1996 3 213 219 (Pubitemid 26266496)
8. Fatty acids in cardiovascular health and disease: a comprehensive update. Baum SJ, Kris-Etherton PM, Willett WC, Lichtenstein AH, Rudel LL, Maki KC, Whelan J, Ramsden CE, Block RC, J Clin Lipidol 2012 6 216 234 10.1016/j.jacl.2012.04.077 22658146
9. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. Jacobson TA, Glickstein SB, Rowe JD, Soni PN, J ClinLipidol 2012 6 5 18
10. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A, Int J Cardiol 2009 136 4 16 10.1016/j.ijcard.2008.03.092 18774613
11. Prediction of coronary heart disease using risk factor categories. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB, Circulation 1998 97 1837 1847 10.1161/01.CIR.97.18.1837 9603539 (Pubitemid 28213628)
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143 3421 12485966
13. LDL size: does it matter? Berneis K, Rizzo M, SwissMedWkly 2004 134 720 724 (Pubitemid 40082987)
14. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects. Lamarche B, Lemieux I, Despres JP, Diabetes Metab 1999 25 199 211 10499189 (Pubitemid 29426371)
15. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. St-Pierre AC, Ruel IL, Cantin B, Dagenais GR, Bernard PM, Despres JP, Lamarche B, Circulation 2001 104 2295 2299 10.1161/hc4401.098490 11696468 (Pubitemid 33049511)
16. Influence of n-3 fatty acids from fish oils on concentration of high- and low-density lipoprotein subfractions and their lipid and apolipoprotein composition. Baumstark MW, Frey I, Berg A, Keul J, Clin Biochem 1992 25 338 340 10.1016/0009-9120(92)80012-6 1490295
17. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, Slaughter S, Cooper JA, Miller GJ, Griffin BA, Am J Clin Nutr 2006 84 1290 1298 17158408 (Pubitemid 44912809)
18. The effect of n-3 fatty acids on low density lipoprotein subfractions. Griffin BA, Lipids 2001 36 Suppl 91 S97 11837999
19. Effect of rosuvastatin monotherapy or in combination with fenofibrate or omega-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome. Agouridis AP, Kostapanos MS, Tsimihodimos V, Kostara C, Mikhailidis DP, Bairaktari ET, Tselepis AD, Elisaf MS, Int J Clin Pract 2012 66 843 853 10.1111/j.1742-1241.2012.02972.x 22897461
20. Beneficial effects of omega-3 fatty acids on low density lipoprotein particle size in patients with type 2 diabetes already under statin therapy. Lee MW, Park JK, Hong JW, Kim KJ, Shin DY, Ahn CW, Song YD, Cho HK, Park SW, Lee EJ, Diabetes Metab J 2013 37 207 211 10.4093/dmj.2013.37.3.207 23807924
21. Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Kelley DS, Siegel D, Vemuri M, Mackey BE, Am J Clin Nutr 2007 86 324 333 17684201 (Pubitemid 47256914)
22. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. Suzukawa M, Abbey M, Howe PR, Nestel PJ, J Lipid Res 1995 36 473 484 7775859
23. Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults. Oelrich B, Dewell A, Gardner CD, Nutr Metab Cardiovasc Dis 2013 23 350 357 10.1016/j.numecd.2011.06.003 21924882
24. Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects. Rivellese AA, Maffettone A, Vessby B, Uusitupa M, Hermansen K, Berglund L, Louheranta A, Meyer BJ, Riccardi G, Atherosclerosis 2003 167 149 158 10.1016/S0021-9150(02)00424-0 12618280 (Pubitemid 36255647)
25. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia. Patti L, Maffettone A, Iovine C, Marino LD, Annuzzi G, Riccardi G, Rivellese AA, Atherosclerosis 1999 146 361 367 10.1016/S0021- 9150(99)00149-5 10532692 (Pubitemid 29418068)
26. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C. Hellstrand S, Sonestedt E, Ericson U, Gullberg B, Wirfalt E, Hedblad B, Orho-Melander M, J Lipid Res 2012 53 1183 1189 10.1194/jlr.P023721 22451038
27. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, Armah CK, Kimber AC, Grew JP, Farrell L, Stannard J, Napper FL, Sala-Vila A, West AL, Mathers JC, Packard C, Williams CM, Calder PC, Minihane AM, AmJ ClinNutr 2008 88 618 629
28. Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the atherosclerosis risk in communities study. Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E, Am J Clin Nutr 2008 87 1926 1931 18541586 (Pubitemid 351872660)
29. Tumor necrosis factor-alpha gene -308 G/A polymorphism modulates the relationship between dietary fat intake, serum lipids, and obesity risk in black South African women. Joffe YT, van der Merwe L, Carstens M, Collins M, Jennings C, Levitt NS, Lambert EV, Goedecke JH, J Nutr 2010 140 901 907 10.3945/jn.109.109355 20335630
30. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Karlsson M, Reue K, Xia YR, Lusis AJ, Langin D, Tornqvist H, Holm C, Gene 2001 272 11 18 10.1016/S0378-1119(01)00559-5 11470505 (Pubitemid 32695393)
31. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P, Piesla MJ, Zhang MY, Bingham B, Uveges A, Kowal D, Garbe D, Kouranova EV, Ring RH, Bates B, Pangalos MN, Kennedy JD, Whiteside GT, Samad TA, Mol Pharmacol 2010 78 996 1003 10.1124/mol.110.068304 20855465
32. Validity and reproducibility of an interviewer-administered food frequency questionnaire for healthy French-Canadian men and women. Goulet J, Nadeau G, Lapointe A, Lamarche B, Lemieux S, NutrJ 2004 3 13
33. CWBC Standardization of Anthropometric Measurements. CW C, The Airlie (VA) Consensus Conference Champaign: Human Kinetics Publishers 1988
34. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. McNamara JR, Schaefer EJ, ClinChimActa 1987 166 1 8 (Pubitemid 17095867)
35. [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins]. Burstein M, Samaille J, ClinChimActa 1960 5 609
36. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Albers JJ, Warnick GR, Wiebe D, King P, Steiner P, Smith L, Breckenridge C, Chow A, Kuba K, Weidman S, Arnett H, Wood P, Shlagenhaft A, ClinChem 1978 24 853 856 (Pubitemid 8357892)
37. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, ClinChem 1972 18 499 502
38. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Laurell CB, AnalBiochem 1966 15 45 52
39. Effects of peroxisome proliferator-activated receptors, dietary fat intakes and gene-diet interactions on peak particle diameters of low-density lipoproteins. Bouchard-Mercier A, Godin G, Lamarche B, Perusse L, Vohl MC, J Nutrigenet Nutrigenomics 2011 4 36 48 10.1159/000324531 21487230
40. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Despres JP, Diabetes Care 1996 19 629 637 10.2337/diacare.19.6.629 8725863 (Pubitemid 26181112)
41. Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Schaefer EJ, Lamon-Fava S, Ausman LM, Ordovas JM, Clevidence BA, Judd JT, Goldin BR, Woods M, Gorbach S, Lichtenstein AH, Am J Clin Nutr 1997 65 823 830 9062535 (Pubitemid 27111091)
42. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Bays HE, Tighe AP, Sadovsky R, Davidson MH, Expert Rev Cardiovasc Ther 2008 6 391 409 10.1586/14779072.6.3.391 18327998
43. Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Kondo A, Muranaka Y, Ohta I, Notsu K, Manabe M, Kotani K, Saito K, Maekawa M, Kanno T, Clin Chem 2001 47 893 900 11325894 (Pubitemid 32398041)
44. Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation. Thifault E, Cormier H, Bouchard-Mercier A, Rudkowska I, Paradis AM, Garneau V, Ouellette C, Lemieux S, Couture P, Vohl MC, J Nutrigenet Nutrigenomics 2013 6 73 82 10.1159/000350744 23689286
45. n-3 fatty acids and serum lipoproteins: human studies. Harris WS, AmJ ClinNutr 1997 65 1645S 1654S (Pubitemid 27187958)
46. Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet. Faghihnia N, Tsimikas S, Miller ER, Witztum JL, Krauss RM, J Lipid Res 2010 51 3324 3330 10.1194/jlr.M005769 20713651
47. Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Cormier H, Rudkowska I, Paradis AM, Thifault E, Garneau V, Lemieux S, Couture P, Vohl MC, Nutrients 2012 4 1026 1041 10.3390/nu4081026 23016130
48. Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level. Harismendy O, Bansal V, Bhatia G, Nakano M, Scott M, Wang X, Dib C, Turlotte E, Sipe JC, Murray SS, Deleuze JF, Bafna V, Topol EJ, Frazer KA, Genome Biol 2010 11 118 10.1186/gb-2010-11-11-r118 21118518
49. Endocannabinoids and the control of energy homeostasis. Kunos G, Osei-Hyiaman D, Liu J, Godlewski G, Batkai S, J Biol Chem 2008 283 33021 33025 10.1074/jbc.R800012200 18694938
50. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Cote M, Matias I, Lemieux I, Petrosino S, Almeras N, Despres JP, Di MV, IntJ Obes(Lond) 2007 31 692 699 (Pubitemid 46482358)
51. Activation of the peripheral endocannabinoid system in human obesity. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, Batkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, Jordan J, Diabetes 2005 54 2838 2843 10.2337/diabetes.54.10.2838 16186383 (Pubitemid 41401077)
52. Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Alberti KG, Zimmet P, Shaw J, Diabet Med 2006 23 469 480 10.1111/j.1464-5491.2006.01858.x 16681555
53. Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up. Mantyselka P, Kautiainen H, Saltevo J, Wurtz P, Soininen P, Kangas AJ, Ala-Korpela M, Vanhala M, Atherosclerosis 2012 223 239 243 10.1016/j.atherosclerosis.2012.05.005 22658258
54. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. Taschler U, Radner FPW, Heier C, Schreiber R, Schweiger M, Schoiswohl G, Preiss-Landl K, Jaeger D, Reiter B, Koefeler HC, Wojciechowski J, Theussl C, Penninger JM, Lass A, Haemmerle G, Zechner R, Zimmermann R, J Biol Chem 2011 286 17467 17477 10.1074/jbc.M110.215434 21454566